SLC3A2 and head and neck squamous cell carcinoma: Consequently, high expression of SLC3A2 and SLC7A5 contributes to the increased radioresistance in HNSCC in vitro and correlates with a worse outcome in patients with HNSCC treated with radiochemotherapy.